NetEase, Inc.: Form 20-F for the period ended Dec 31, 2020
Filed with the SEC on Apr 28, 2021 and accepted by EDGAR at Apr 28, 2021, 06:06 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2020-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2020-01-01 to 2020-12-31 | $11.29bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months2020-01-01 to 2020-12-31 | $5.32bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 12 months2020-01-01 to 2020-12-31 | $5.97bn | us-gaap:GrossProfit |
| Research and development | 12 months2020-01-01 to 2020-12-31 | $1.59bn | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2020-01-01 to 2020-12-31 | $2.23bn | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months2020-01-01 to 2020-12-31 | $466.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2020-01-01 to 2020-12-31 | $1.89bn | us-gaap:ProfitLoss |
| Diluted EPS | 12 months2020-01-01 to 2020-12-31 | $0.55 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2020-01-01 to 2020-12-31 | $0.56 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2020-01-01 to 2020-12-31 | 3,349,759,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2020-01-01 to 2020-12-31 | $3.81bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2020-01-01 to 2020-12-31 | $161.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months2020-01-01 to 2020-12-31 | $656.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | At period end2020-12-31 | $1.40bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2020-12-31 | $16.53bn | us-gaap:AssetsCurrent |
| Total assets | At period end2020-12-31 | $21.74bn | us-gaap:Assets |
| Current liabilities | At period end2020-12-31 | $7.16bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2020-12-31 | $7.37bn | us-gaap:Liabilities |
| Shareholders' equity | At period end2020-12-31 | $12.59bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2020-12-31 | 3,349,335,066 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001104659-21-055902. Last ingested by Listed: Nov 6, 2026, 11:02 ET. Listed shows no prices and gives no investment advice.